Cyclacel
Investors & Media

News

All Releases
View Summary Cyclacel Announces Data Safety Monitoring Board Recommendation to Continue the SEAMLESS Phase 3 Trial of Sapacitabine in AML
Nov 25, 2013
PDF 13.2 KB Add to Briefcase
View Summary Cyclacel Reports Third Quarter 2013 Financial Results
Nov 12, 2013
PDF 26.8 KB Add to Briefcase
View Summary Researchers to Present New Phase 2 Data on Sapacitabine as a Treatment for Patients With MDS at ASH Annual Meeting
Nov 7, 2013
PDF 16.6 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to Release Third Quarter 2013 Financial Results
Nov 6, 2013
PDF 12.9 KB Add to Briefcase
View Summary New US Patents Issued Covering Sapacitabine Use With Hypomethylating Agents and Sapacitabine Dosing Regimens
Nov 5, 2013
PDF 15.9 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to Present at the 2013 Therapeutic Area Partnerships Conference
Oct 31, 2013
PDF 15.4 KB Add to Briefcase
View Summary Cyclacel's Sapacitabine Reported to Have Anti-Tumor Activity Against Ovarian Cancer
Sep 19, 2013
PDF 18.2 KB Add to Briefcase
View Summary Cyclacel Reports Second Quarter 2013 Financial Results
Aug 14, 2013
PDF 27.2 KB Add to Briefcase
View Summary Cyclacel's Seliciclib to be Evaluated in Investigator-Initiated Clinical Study to Treat Rheumatoid Arthritis
Aug 12, 2013
PDF 13.7 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to Announce Release of Second Quarter 2013 Financial Results
Aug 8, 2013
PDF 11.4 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to Present at the JMP Securities Healthcare Conference 2013
Jul 5, 2013
PDF 12.5 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals Announces Closing of Underwritten Offering
May 21, 2013
PDF 13.4 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals Announces $20 Million Underwritten Offering
May 16, 2013
PDF 14.2 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 15, 2013
PDF 13.6 KB Add to Briefcase
View Summary Cyclacel Reports First Quarter 2013 Financial Results
May 13, 2013
PDF 26.1 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to Announce Release of First Quarter 2013 Financial Results
May 10, 2013
PDF 12.2 KB Add to Briefcase
View Summary Cyclacel Reports Updated Phase 2 Survival Data of Sapacitabine for MDS
Apr 30, 2013
PDF 18.4 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference
Apr 23, 2013
PDF 12.3 KB Add to Briefcase
View Summary Combination Potential of Cyclacel's Sapacitabine and Seliciclib Reported at AACR
Apr 9, 2013
PDF 18.7 KB Add to Briefcase
View Summary AACR Press Conference Highlights Combination Potential of Two Cyclacel Drugs
Apr 8, 2013
PDF 13.9 KB Add to Briefcase
Showing 81-100 of 342 Page: 1 2 3 4 5 6 7 8 9 ... 18  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
Investors & Media